Related Experiment Video
Updated: Jul 20, 2026
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Hepatitis C virus entry: an intriguing challenge for drug discovery
1The Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA. Nicholas.Meanwell@bms.com
Current Opinion in Investigational Drugs (London, England : 2000)
|September 8, 2006
Summary
Understanding hepatitis C virus (HCV) entry into cells is crucial for drug discovery. A new infectious HCV system allows detailed study of viral entry mechanisms for developing targeted therapies.
Area of Science:
- Virology
- Hepatology
- Drug Discovery
Background:
- Hepatitis C virus (HCV) entry is essential for replication but poorly understood.
- Previous studies relied on pseudoparticles, lacking full viral life-cycle authenticity.
- Limited understanding hinders the development of effective antiviral strategies.
Purpose of the Study:
- To detail the mechanisms of HCV entry into host cells.
- To leverage a newly developed infectious HCV replication system for authentic study.
- To identify and validate drug targets within the HCV entry pathway.
Main Methods:
- Utilizing a novel infectious hepatitis C virus (HCV) replication system.
- Examining the interactions between HCV glycoproteins (E1 and E2) and host cell receptors.
- Investigating the mechanism of action of weak entry inhibitors using infectious virus.
Main Results:
- The infectious HCV system enables more authentic study of viral entry.
- Weak inhibitors' mechanisms remain unclear and require validation with infectious virus.
- HCV entry likely involves unique biochemical events distinct from other viruses.
Conclusions:
- The infectious HCV system is a promising tool for elucidating viral entry mechanisms.
- Understanding HCV entry is key for developing novel antiviral drugs.
- Further research is needed to fully characterize HCV entry and exploit it for therapeutic interventions.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:14Hepatic Drug Clearance: Role of Transporters
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...